Literature DB >> 8938428

A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis.

M R Johnson1, M H Polymeropoulos, H L Vos, R I Ortiz de Luna, C A Francomano.   

Abstract

Pycnodysostosis (MIM 265800) is a rare, autosomal recessive skeletal dysplasia characterized by short stature, wide cranial sutures, and increased bone density and fragility. Linkage analysis localized the disease gene to human chromosome 1q21, and subsequently the genetic interval was narrowed to between markers D1S2612 and D1S2345. Expressed sequence tagged markers corresponding to cathepsin K, a cysteine protease highly expressed in osteoclasts and thought to be important in bone resorption, were mapped previously in the candidate region. We have identified a cytosine to thymidine transition at nucleotide 862 (GenBank accession no. S79895) of the cathepsin K coding sequence in the DNA of an affected individual from a large, consanguinous Mexican family. This mutation results in an arginine to STOP alteration at amino acid 241, predicting premature termination of cathepsin K mRNA translation. All affected individuals in this family were homozygous for the mutation, suggesting that this alteration may lead to pycnodysostosis. Recognition of the role of cathepsin K in the etiology of pycnodysostosis should provide insights into the pathogenesis and treatment of other disorders of bone remodeling, including osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938428     DOI: 10.1101/gr.6.11.1050

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  18 in total

1.  Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

Authors:  W S Hou; D Brömme; Y Zhao; E Mehler; C Dushey; H Weinstein; C S Miranda; C Fraga; F Greig; J Carey; D L Rimoin; R J Desnick; B D Gelb
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.

Authors:  A F Schilling; C Mülhausen; W Lehmann; R Santer; T Schinke; J M Rueger; M Amling
Journal:  Osteoporos Int       Date:  2007-01-06       Impact factor: 4.507

3.  Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts.

Authors:  Viviana Cremasco; Corinne E Decker; Deborah Stumpo; Perry J Blackshear; Keiichi I Nakayama; Keiko Nakayama; Traian S Lupu; Daniel B Graham; Deborah V Novack; Roberta Faccio
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

Review 4.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

5.  Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.

Authors:  Wei Chen; Shuying Yang; Yoke Abe; Ming Li; Yucheng Wang; Jianzhong Shao; En Li; Yi-Ping Li
Journal:  Hum Mol Genet       Date:  2007-01-08       Impact factor: 6.150

6.  Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.

Authors:  Lingxin Zhu; Yi Tang; Xiao-Yan Li; Evan T Keller; Jingwen Yang; Jung-Sun Cho; Tamar Y Feinberg; Stephen J Weiss
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

7.  ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized rats.

Authors:  Yasuo Ochi; Hiroyuki Yamada; Hiroshi Mori; Naoki Kawada; Ryoji Kayasuga; Yasutomo Nakanishi; Makoto Tanaka; Akira Imagawa; Kazuyuki Ohmoto; Kazuhito Kawabata
Journal:  J Bone Miner Metab       Date:  2013-12-08       Impact factor: 2.626

8.  Molecular biology of bone remodelling.

Authors:  Nadia Rucci
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

9.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Authors:  Sutada Lotinun; Riku Kiviranta; Takuma Matsubara; Jorge A Alzate; Lynn Neff; Anja Lüth; Ilpo Koskivirta; Burkhard Kleuser; Jean Vacher; Eero Vuorio; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 10.  Osteopetrosis.

Authors:  Zornitza Stark; Ravi Savarirayan
Journal:  Orphanet J Rare Dis       Date:  2009-02-20       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.